Stock Price
0.45
Daily Change
-0.04 -8.25%
Monthly
27.14%
Yearly
270.83%
Q1 Forecast
0.49

Starpharma Holdings reported AUD15.41M in Cash and Equivalent for its fiscal semester ending in June of 2025.





Cash And Equivalent Change Date
Medical Developments International AUD 17.84M 219K Jun/2025
Mesoblast USD 161.16M 98.6M Jun/2025
Neuren Pharmaceuticals AUD 5.91M 2.76M Jun/2025